It should be noted that many Tylenol lawsuits claim that plaintiffs suffered liver injuries despite using these drugs in accordance with label directions.
New York, New York (PRWEB) February 10, 2014
As Tylenol lawsuits (http://www.tylenollawsuitcenter.com/) continue to mount in courts around the country, Bernstein Liebhard LLP notes that McNeil Consumer Healthcare, the manufacturer of Tylenol-brand medications, has launched an acetaminophen safety campaign to increase awareness of the potential for Tylenol to cause liver damage. Among other things, a flier recently issued by the company in conjunction with CVS stores nationwide reminds consumers to avoid using more than one acetaminophen-containing product to avoid harm to their liver.*
“In light of the serious risks associated with acetaminophen-overdose, the action is commendable. But it should be noted that many Tylenol lawsuits claim that plaintiffs suffered liver injuries despite using these drugs in accordance with label directions,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is offering free legal reviews to alleged victims of Tylenol and liver damage.
Tylenol Liver Damage Allegations
According to court documents, more than 100 Tylenol lawsuits alleging a connection between the use of these products and serious liver damage have been filed in a federal multidistrict litigation now underway in U.S. District Court, Eastern District of Pennsylvania. Many of the claims pending in the proceeding allege that the use of Tylenol products resulted in liver injuries serious enough to result in hospitalization, liver transplantation and death. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)
Last summer, McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, announced that it would add new, more prominent warnings regarding the risk of liver damage to the labels of Tylenol-brand medications. According to a report published by Bloomberg.com at the time, bottles of Extra Strength Tylenol received the new labels in October, while other medications in the line are expected to follow.**
In 2011, the U.S. Food & Drug Administration (FDA) announced that it would limit the amount of acetaminophen in prescription medications to 325 mg per tablet. According to a notice posted on the Federal Register, the new limits went into affect on January 14, 2014. However, according to Bloomberg.com, Extra Strength Tylenol caplets each contain 500 mg of acetaminophen, well over the new limits for prescription medications set by the FDA.**
Alleged victims of Tylenol and liver damage may be entitled to compensation for injury-related damages, including out-of-pocket medical expenses, lost wages, pain and suffering, and more. To learn more about filing a Tylenol lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free legal review, please call 800-511-5092.
*forbes.com/sites/davidkroll/2014/02/06/cvs-continues-to-impress-acetaminophen-safety/, Forbes.com, February 6, 2014
**bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP